Compare PRQR & RDCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRQR | RDCM |
|---|---|---|
| Founded | 2012 | 1985 |
| Country | Netherlands | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.5M | 182.4M |
| IPO Year | 2014 | 1999 |
| Metric | PRQR | RDCM |
|---|---|---|
| Price | $1.48 | $11.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $6.80 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 291.4K | 41.5K |
| Earning Date | 03-12-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $18.88 | $11.50 |
| Revenue Next Year | N/A | $9.74 |
| P/E Ratio | ★ N/A | $16.35 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.08 | $9.88 |
| 52 Week High | $3.10 | $15.14 |
| Indicator | PRQR | RDCM |
|---|---|---|
| Relative Strength Index (RSI) | 43.57 | 58.54 |
| Support Level | $1.33 | $10.65 |
| Resistance Level | $1.58 | $13.65 |
| Average True Range (ATR) | 0.12 | 0.57 |
| MACD | -0.03 | 0.17 |
| Stochastic Oscillator | 26.00 | 57.96 |
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.
Radcom Ltd Ltd is engaged in providing network intelligence, 5G ready cloud-native, network intelligence solutions for telecom operators transitioning to 5G. The company has a network intelligence solution for 5G namely Radcom ACE. Its products consist of Radcom Network Visibility, Radcom Service Assurance, and Radcom Network Insights. It has offices in Israel, the United States, Brazil, and India. Key revenue is derived from sales in North America.